Birdwatch Note
2023-03-23 15:46:52 UTC - NOT_MISLEADING
At this time, CDC and FDA recommend clinicians and patients stop using EzriCare or Delsam Pharma’s Artificial Tears products pending additional guidance from CDC and FDA. https://www.cdc.gov/hai/outbreaks/crpa-artificial-tears.html
Written by 05CF6C6BEF86429994274A0C035BB6215BCD64B2F8AF7AE21468A6745E9976AC
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1638884936085282816
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1638930318542401537
- noteId - 1638930318542401537
- participantId -
- noteAuthorParticipantId - 05CF6C6BEF86429994274A0C035BB6215BCD64B2F8AF7AE21468A6745E9976AC Participant Details
- createdAtMillis - 1679586412451
- tweetId - 1638884936085282816
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- At this time, CDC and FDA recommend clinicians and patients stop using EzriCare or Delsam Pharma’s Artificial Tears products pending additional guidance from CDC and FDA. https://www.cdc.gov/hai/outbreaks/crpa-artificial-tears.html
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-03-23 15:46:52 UTC (1679586412451) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-24 02:40:31 UTC (1679625631780) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-03-23 18:31:35 -0500 | Rating Details | |
| 2023-03-23 18:16:53 -0500 | Rating Details | |
| 2023-03-23 15:41:57 -0500 | Rating Details | |
| 2023-03-23 14:40:40 -0500 | Rating Details | |
| 2023-03-23 13:31:08 -0500 | Rating Details | |
| 2023-03-23 13:25:21 -0500 | Rating Details | |
| 2023-03-23 13:08:42 -0500 | Rating Details | |
| 2023-03-23 12:57:34 -0500 | Rating Details | |
| 2023-03-23 12:07:06 -0500 | Rating Details | |
| 2023-03-23 11:48:44 -0500 | Rating Details | |
| 2023-03-23 11:17:01 -0500 | Rating Details | |
| 2023-03-23 11:02:23 -0500 | Rating Details | |
| 2023-03-23 23:51:44 -0500 | Rating Details | |
| 2023-03-23 23:22:45 -0500 | Rating Details | |
| 2023-03-23 21:34:42 -0500 | Rating Details | |
| 2023-03-23 21:30:52 -0500 | Rating Details | |
| 2023-03-23 20:49:25 -0500 | Rating Details | |
| 2023-03-25 00:33:02 -0500 | Rating Details | |
| 2023-03-24 23:53:06 -0500 | Rating Details | |
| 2023-03-25 00:33:02 -0500 | Rating Details | |
| 2023-03-24 23:53:06 -0500 | Rating Details | |
| 2023-03-23 13:08:42 -0500 | Rating Details | |
| 2023-03-23 11:17:01 -0500 | Rating Details | |
| 2023-03-23 23:22:45 -0500 | Rating Details | |
| 2023-03-23 12:57:34 -0500 | Rating Details | |
| 2023-03-23 15:41:57 -0500 | Rating Details | |
| 2023-03-23 11:48:44 -0500 | Rating Details | |
| 2023-03-23 13:31:08 -0500 | Rating Details | |
| 2023-03-23 21:30:52 -0500 | Rating Details | |
| 2023-03-23 21:34:42 -0500 | Rating Details | |
| 2023-03-23 18:16:53 -0500 | Rating Details | |
| 2023-03-23 18:31:35 -0500 | Rating Details | |
| 2023-03-23 11:02:23 -0500 | Rating Details | |
| 2023-03-23 13:25:21 -0500 | Rating Details | |
| 2023-03-23 14:40:40 -0500 | Rating Details | |
| 2023-03-23 12:07:06 -0500 | Rating Details | |
| 2023-03-23 20:49:25 -0500 | Rating Details | |
| 2023-03-23 23:51:44 -0500 | Rating Details |